Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
ASGCT's members have the ability to direct the Society by voting for ASGCT's Board of Directors before April 20.
Members, Transitional Members, and Emeritus Members of ASGCT are invited to vote for the four open positions on the Board of Directors. All candidates selected will join the ASGCT Board of Directors on June 1, 2021 and serve their terms through May 31, 2024. Vice presidents of ASGCT serve as the vice president in the first year of their term and rise to president-elect and president in the second and third years of their term, respectively. The election is open from March 23 through April 20 to all members and transitional members who have renewed for the 2021 membership year.
University of Washington
Memorial Sloan Kettering Cancer Center
National Institutes of Health
Hannover Medical School
Cima-Universidad de Navarra Vivet Therapeutics
Regenxbio, Inc.
Stanford University
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico